Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Biologic Imaging Reagents Market from 2024 to 2025?

There has been a swift growth in the market size of biologic imaging reagents in the last few years. It is projected to escalate from $18.41 billion in 2024 to $20.26 billion in 2025, with a compound annual growth rate (CAGR) of 10.0%. Factors such as the growing prevalence of chronic illnesses, increased investment in research and development, a shift towards individualized medicine, emphasis on detecting diseases at an early stage, an aging population, and partnerships in biomedical research have all contributed to the growth witnessed in the historical period.

What Is the Projected Market Size of the Biologic Imaging Reagents Market?

In the coming years, the biologic imaging reagents market is projected to experience robust growth. It is predicted to escalate to $27.78 billion by 2029, with an 8.2% compound annual growth rate (CAGR). This surge during the predicted period is due to the broadening applications in pharmaceutical advancements, the escalating demand for molecular imaging, an emphasis on non-invasive diagnosis methods, a global surge in cancer instances, and a move towards value-based healthcare. Upcoming trends for this period include an increasing need for contrast-enhanced imaging agents, the invention of targeted molecular imaging agents, the application of nanoparticles in imaging, the advent of fluorescent probes for in vivo imaging, and the integration of artificial intelligence into image interpretation.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13389&type=smp

Who are the Major Competitors in the Biologic Imaging Reagents Market Outlook?

Major companies operating in the biologic imaging reagents market report are Cardinal Health Inc., Johnson And Johnson Services Inc., Bayer Healthcare AG, Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Dickinson and Company (BD), Koninklijke Philips N.V., GE HealthCare Technologies Inc., Stryker Corporation, FluoroPharma Medical Inc., Lonza Group AG, Illumina Inc., PerkinElmer Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bracco Diagnostics Inc., Leica Microsystems GmbH, Lantheus Medical Imaging Inc., Guerbet SA, Miltenyi Biotec B.V. and Co. KG, Promega Corporation, Abcam plc., Luminex Corporation, MILabs, LI-COR Biosciences, FUJIFILM VisualSonics Inc., Advanced Proteome Therapeutics Incorporated, BIOPRO Baden-Württemberg GmbH, ABX Advanced Biochemical Compounds GmbH

What Is Fueling Growth in the Biologic Imaging Reagents Market?

The escalating instances of chronic diseases are anticipated to stimulate the expansion of the biologic imaging reagents market moving ahead. Chronic ailments, ones that persist for a year or longer and demand ongoing medical care, could gradually deteriorate. To diagnose and identify such diseases, biologic imaging reagents are crucial as they allow for the observation of organs and compromised structures. For example, the American Cancer Society projected that there would be approximately 1.9 million new cases of cancer and 609,360 cancer-related deaths in the US in 2022. In addition, the National Library of Medicine reported that the number of US citizens above the age of 50, suffering from at least one chronic illness, would surge by 99.5%, from 71.522 million to 142.66 million, by 2050. Hence, the rising prevalence of chronic ailments is fuelling the expansion of the biologic imaging reagents market. The burgeoning demand for personalized medicine is projected to drive the growth of the biologic imaging reagents market further. Personalized medicine, a healthcare strategy customized to the distinct characteristics of each patient, relies on biologic imaging reagents for visualizing and assessing biological processes at the molecular and cellular level, customized to individual patients. For instance, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022, according to the Personalized Medicine Coalition, a US-based membership organization. Furthermore, nearly 34%, or rather 12, of the 35 therapeutic NMEs were deemed as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the escalating demand for personalized medicine is prompting the growth of the biologic imaging reagents market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13389&type=smp

Which Biologic Imaging Reagents Market Segments Are Growing the Fastest?

The biologic imaging reagents market covered in this report is segmented –

1) By Product: Contrast Reagents, Optical Imaging Reagents, Radiopharmaceuticals

2) By Modality: Magnetic Resonance Imaging (MRI), Ultrasound, X-Ray And Computerized Tomography (CT), Nuclear, Optical Imaging, Other Modalities

3) By Application: In Vitro, In Vivo

4) By End User: Diagnostic Laboratories, Imaging Centers, Life Science Companies, Research And Academic Institutes, Other End Users

Subsegments:

1) By Contrast Reagents: X-ray Contrast Agents, MRI Contrast Agents, Ultrasound Contrast Agents

2) By Optical Imaging Reagents: Fluorescent Dyes, Bioluminescent Reagents, Quantum Dots

3) By Radiopharmaceuticals: Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals

Which Industry Trends Are Shaping the Future of the Biologic Imaging Reagents Market?

Leading corporations in the biologic imaging reagent market are concentrating their efforts on the creation of innovative reagents such as new dye technology. This provides scientists and medical professionals with a fresh approach to enhancing the sensitivity and specificity of biological imaging. The term novel dye technology pertains to the production of novel dyes for a range of applications, including biological imaging. In April 2022, for example, Becton, Dickinson, and Company, a medical device company from the United States, unveiled BD Horizon RealYellow 586 Reagents and RealBlue Reagents. This new reagent group offers researchers enhanced data resolution and deeper insights from their samples than the conventional fluorochrome can provide. This is credited to the use of breakthrough dye technology and artificial intelligence (AI) oversight. The AI reviewed the available data from the excitation and emission profiles of commercially accessible fluorochromes and subsequently identified the optimal locations in laser lines for the creation of new dyes.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/biologic-imaging-reagents-global-market-report

Which Countries Are Leading the Biologic Imaging Reagents Market?

North America was the largest region in the biologic imaging reagents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologic imaging reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13389

This Report Delivers Insight On:

1. How big is the biologic imaging reagents market, and how is it changing globally?

2. Who are the major companies in the biologic imaging reagents market, and how are they performing?

3. What are the key opportunities and risks in the biologic imaging reagents market right now?

4. Which products or customer segments are growing the most in the biologic imaging reagents market?

5. What factors are helping or slowing down the growth of the biologic imaging reagents market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model